Kunzeachromone A



Compound IDCDAMM02022
Common nameKunzeachromone A
IUPAC name[2-(5,7-dihydroxy-4-oxo-2-propan-2-ylchromen-6-yl)-5-hydroxy-6-(hydroxymethyl)-3-(3,4,5-trihydroxybenzoyl)oxyoxan-4-yl] 3,4,5-trihydroxybenzoate
Molecular formulaC32H30O17

Experimental data

Retention time24.55
Adduct[2M+NH4]+
Actual mz1390.31
Theoretical mz1390.33
Error14.26
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.4588

Identifiers and class information

Inchi keyULJVHBGFMDKGQH-CLKAYMIJNA-N
SmilesO=C(OC1C(O)C(OC(C2=C(O)C=C3OC(=CC(=O)C3=C2O)C(C)C)C1OC(=O)C4=CC(O)=C(O)C(O)=C4)CO)C5=CC(O)=C(O)C(O)=C5
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)8
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)16
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)686.579
Computed dipole moment(dipole)5.393
Total solvent accessible surface area (SASA)823.025
Hydrophobic component of SASA (FOSA)204.138
Hydrophilic component of SASA (FISA)450.257
Pie component of the SASA (PISA)168.63
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1715.69
Number of hydrogen bond donors (donorHB)9
Number of hydrogen bond acceptors (accptHB)16.6
Free energy of solvation of dipole (dip^2/V)0.0169542
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0605085
Globularity descriptor (glob)0.842127
Predicted polarizability in cubic angstroms (QPpolrz)53.845
Predicted hexadecane/gas partition coefficient (QPlogPC16)20.208
Predicted octanol/gas partition coefficient (QPlogPoct)41.708
Predicted water/gas partition coefficient (QPlogPw)31.912
Predicted octanol/water partition coefficient (QPlogPo/w)-0.53
Predicted aqueous solubility (QPlogS)-2.951
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.233
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.891
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.532
Predicted brain/blood partition coefficient (QPlogBB)-4.634
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.143
Predicted skin permeability, log Kp (QPlogKp)-7.688
PM3 calculated ionization potential (IP(ev))9.258
PM3 calculated electron affinity (EA(eV))0.773
Number of likely metabolic reactions (#metab)13
Prediction of binding to human serum albumin (QPlogKhsa)-0.56
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)307.529
Number of nitrogen and oxygen atoms (#NandO)17
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P05121SERPINE1Plasminogen activator inhibitor-1T15556SEA
P60568IL2Interleukin-2T61698SEA
Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
P17931LGALS3Galectin-3T72038SEA
P14679TYRTyrosinaseT97035SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA
P63316TNNC1Troponin, cardiac muscleT12966SEA
P09382LGALS1Galectin-1T09544SEA
Q13332PTPRSReceptor-type tyrosine-protein phosphatase ST10147SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P05231IL6Interleukin-6T32578SEA
Q99417MYCBPMYCBP messenger RNAT37298SEA
P16220CREB1Cyclic AMP-responsive element-binding proteinT92098SEA
P19429TNNI3Cardiac troponin IT20186SEA
P45379TNNT2Cardiac muscle troponin TT05887SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T15556DI0037Asthma[ICD-11: CA23]P05121SERPINE1
T15556DI0405Thrombosis[ICD-11: DB61-GB90]P05121SERPINE1
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T12966DI0006Acquired cutaneous blood vessel malformation[ICD-11: EF20]P63316TNNC1
T12966DI0175Heart failure[ICD-11: BD10-BD1Z]P63316TNNC1
T10147DI0057Bone paget disease[ICD-11: FB85]Q13332PTPRS
T32578DI0028Anemia[ICD-11: 3A00-3A9Z]P05231IL6
T37298DI0235Liver cancer[ICD-11: 2C12]Q99417MYCBP

Copyright © 2025